Cargando…

Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man

Patient: Male, 54 Final Diagnosis: Recurrent torsades de pointes Symptoms: Sudden cardiac death Medication: — Clinical Procedure: — Specialty: Cardiology OBJECTIVE: Congenital defects/diseases BACKGROUND: QT prolongation is a common, easily overlooked clinical problem with potentially dire consequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guess, Joel, Hubel, Kinsley, Wiggins, Amanda, Madigan, Cory G., Bunin, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322060/ https://www.ncbi.nlm.nih.gov/pubmed/30568157 http://dx.doi.org/10.12659/AJCR.912326

Ejemplares similares

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Recurrent takotsubo with prolonged QT and torsade de pointes and left ventricular thrombus
por: Ahmed, Alaa Eldin K., et al.
Publicado: (2017)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Shock From Twisting Peaks: A Rare Case of Recurrent Torsades de Pointes Secondary to Leuprolide-Induced Prolonged QT
por: Abbasi, Danish, et al.
Publicado: (2020)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation
por: Ösken, Altuğ, et al.
Publicado: (2016)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2017)

The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department
por: Cole, Jon B., et al.
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

QT Prolongation Complicated with Torsades de Pointes in Prosthetic Mitral Valve Endocarditis: A Case Report
por: Tounsi, A., et al.
Publicado: (2012)

QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H(1) receptor antagonists
por: Acosta-Materán, Carlos, et al.
Publicado: (2016)

Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug
por: Schlit, Anne‐Françoise, et al.
Publicado: (2017)

A Case of Hypoglycemiainduced QT Prolongation Leading to Torsade de Pointes and a Review of Pathophysiological Mechanisms
por: Hannoodi, Faris, et al.
Publicado: (2017)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Comment on “The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department”
por: DiSalvo, Philip C., et al.
Publicado: (2021)

His Bundle Pacing in Amiodarone-Induced Complete Heart Block, QT Prolongation, and Torsade de Pointes
por: Tan, Vern Hsen, et al.
Publicado: (2020)

Torsade de Pointes Due to QT Prolongation after Pulmonary Vein Isolation for Persistent Atrial Fibrillation
por: Chikata, Akio, et al.
Publicado: (2021)

Diphenhydramine-Induced Torsade De Pointes With Pharmacological Cardioversion in a Patient With Methadone-Induced QT Prolongation
por: Hoffman, Jamie P, et al.
Publicado: (2022)

QT Dispersion and Drug-Induced Torsade de Pointes
por: Friedman, Ari, et al.
Publicado: (2021)

QT interval prolongation and torsade de pointes induced by left ventricular pacing rescued by His bundle pacing
por: Lador, Adi, et al.
Publicado: (2020)

Prolonged QT interval in a man with anorexia nervosa
por: Macías-Robles, María Dolores, et al.
Publicado: (2009)

Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
por: El-Sherif, Nabil, et al.
Publicado: (2019)

Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System
por: Teng, Chengwen, et al.
Publicado: (2019)

Isoproterenol suppresses recurrent torsades de pointes in a patient with long QT syndrome type 2
por: Suarez, Keith, et al.
Publicado: (2018)

Torsades De Pointes in a 71-Year-Old Female With Normal Qt Interval After Azithromycin Use
por: Foster, Allison, et al.
Publicado: (2023)

Long QT Syndrome and Torsade de Pointes Associated with Takotsubo Cardiomyopathy
por: Ahn, Ji Hun, et al.
Publicado: (2011)

Long QT syndrome and torsade de pointes after anthracycline chemotherapy
por: Colombo, N, et al.
Publicado: (2009)

A 54 -Year-Old Man with Cough and Dyspnea
por: Pourdowlat, Guitti, et al.
Publicado: (2012)

3542 Torsade de pointes/QT prolongation risks with antibiotics: A contemporary analysis of the FDA Adverse Event Reporting System
por: Teng, Chengwen, et al.
Publicado: (2019)

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study
por: Hafermann, Matthew J, et al.
Publicado: (2011)

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
por: Jankelson, Lior, et al.
Publicado: (2020)

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2010)

Drug-Induced Long-QT and Torsades de Pointes in Elderly Polymedicated Patients
por: García-Fuertes, Daniel, et al.
Publicado: (2016)

Long QT syndrome and torsades de pointes complicating mitral valve replacement
por: Gilbert, Shegu, et al.
Publicado: (2016)

A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation
por: Shimizu, Masato, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rst9ll75mkulin31gg51rsr4m6